Cargando…
An exploration of the experience of dapagliflozin in clinical practice
Despite the availability of established treatments, heart failure (HF) is associated with a poor prognosis and suboptimal management, highlighting the need for new treatment and prevention options. It is suggested that sodium-glucose cotransporters 2 inhibitors can provide a beneficial therapeutic a...
Autores principales: | Anitha, Anuba Paulvarnan, Balasubramanian, Swetha, Ramalingam, Arun Gopal, Samuel Kennady, Shini Rubina, Ganamurali, Nila, Dhanasekaran, Dhivya, Sabarathinam, Sarvesh |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Future Science Ltd
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9704035/ https://www.ncbi.nlm.nih.gov/pubmed/36457541 http://dx.doi.org/10.2144/fsoa-2022-0038 |
Ejemplares similares
-
Artificial sweetener is a growing threat for metabolic syndrome: why is extra attention required?
por: Sabarathinam, Sarvesh, et al.
Publicado: (2023) -
Therapeutic use of Guggulsterone in COVID-19 induced obesity (COVIBESITY) and significant role in immunomodulatory effect
por: Preethi, L., et al.
Publicado: (2021) -
Junk food-induced obesity- a growing threat to youngsters during the pandemic
por: Singh S, Ankul, et al.
Publicado: (2021) -
Drug interaction risk between cardioprotective drugs and drugs used in treatment of COVID-19: A evidence-based review from six databases
por: S K, Shini Rubina, et al.
Publicado: (2022) -
A glycemic diet improves the understanding of glycemic control in diabetes patients during their follow-up
por: Sabarathinam, Sarvesh
Publicado: (2023)